ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Zerhouni Starts Work As NIH Director

May 24, 2002

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Chemoprevention Clinical Trial RFA Being Developed For January Concept Review, Along With “Bridge” RFA

November 27, 1981

In Brief: Markup Of Cancer Act Renewal Bill Oct. 31; Garfinkel New ACS VP For Epidemiology

October 19, 1979

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

April 5, 1974